It was reported that on (b)(6) 2011, the patient underwent a stenting procedure with implantation of a 4.0 x 12 mm xience v stent in the proximal left anterior descending artery.On an unspecified date, the patient expired due to unknown cause.No autopsy was performed.No additional information was provided.
|
(b)(4).Date of death: estimated as (b)(6) 2014.Date of event: estimated as (b)(6) 2014.There was no reported device malfunction.It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.Death is listed in the xience v everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.Based on the information reviewed, there is no evidence to indicate the presence of a product deficiency.
|